K Svensson1, S A LaBarge1, V F Martins1, S Schenk1,2. 1. Department of Orthopaedic Surgery, University of California San Diego, La Jolla, CA, USA. 2. Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA.
Abstract
AIMS: Activation of the NAD+ dependent protein deacetylase SIRT1 has been proposed as a therapeutic strategy to treat mitochondrial dysfunction and insulin resistance in skeletal muscle. However, lifelong overexpression of SIRT1 in skeletal muscle does not improve parameters of mitochondrial function and insulin sensitivity. In this study, we investigated whether temporal overexpression of SIRT1 in muscle of adult mice would affect skeletal muscle mitochondrial function and insulin sensitivity. METHODS: To circumvent potential effects of germline SIRT1 overexpression, we utilized an inducible model of SIRT1 overexpression in skeletal muscle of adult mice (i-mOX). Insulin sensitivity was assessed by 2-deoxyglucose uptake, muscle maximal respiratory function by high-resolution respirometry and systemic energy expenditure was assessed by whole body calorimetry. RESULTS: Although SIRT1 was highly, and specifically, overexpressed in skeletal muscle of i-mOX compared to WT mice, glucose tolerance and skeletal muscle insulin sensitivity were comparable between genotypes. Additionally, markers of mitochondrial biogenesis, muscle maximal respiratory function and whole-body oxygen consumption were also unaffected by SIRT1 overexpression. CONCLUSION: These results support previous work demonstrating that induction of SIRT1 in skeletal muscle, either at birth or in adulthood, does not impact muscle insulin action or mitochondrial function.
AIMS: Activation of the NAD+ dependent protein deacetylase SIRT1 has been proposed as a therapeutic strategy to treat mitochondrial dysfunction and insulin resistance in skeletal muscle. However, lifelong overexpression of SIRT1 in skeletal muscle does not improve parameters of mitochondrial function and insulin sensitivity. In this study, we investigated whether temporal overexpression of SIRT1 in muscle of adult mice would affect skeletal muscle mitochondrial function and insulin sensitivity. METHODS: To circumvent potential effects of germline SIRT1 overexpression, we utilized an inducible model of SIRT1 overexpression in skeletal muscle of adult mice (i-mOX). Insulin sensitivity was assessed by 2-deoxyglucose uptake, muscle maximal respiratory function by high-resolution respirometry and systemic energy expenditure was assessed by whole body calorimetry. RESULTS: Although SIRT1 was highly, and specifically, overexpressed in skeletal muscle of i-mOX compared to WT mice, glucose tolerance and skeletal muscle insulin sensitivity were comparable between genotypes. Additionally, markers of mitochondrial biogenesis, muscle maximal respiratory function and whole-body oxygen consumption were also unaffected by SIRT1 overexpression. CONCLUSION: These results support previous work demonstrating that induction of SIRT1 in skeletal muscle, either at birth or in adulthood, does not impact muscle insulin action or mitochondrial function.
Authors: Min Lu; David A Sarruf; Pingping Li; Olivia Osborn; Manuel Sanchez-Alavez; Saswata Talukdar; Ai Chen; Gautam Bandyopadhyay; Jianfeng Xu; Hidetaka Morinaga; Kevin Dines; Steven Watkins; Karl Kaiyala; Michael W Schwartz; Jerrold M Olefsky Journal: J Biol Chem Date: 2013-03-01 Impact factor: 5.157
Authors: Jill C Milne; Philip D Lambert; Simon Schenk; David P Carney; Jesse J Smith; David J Gagne; Lei Jin; Olivier Boss; Robert B Perni; Chi B Vu; Jean E Bemis; Roger Xie; Jeremy S Disch; Pui Yee Ng; Joseph J Nunes; Amy V Lynch; Hongying Yang; Heidi Galonek; Kristine Israelian; Wendy Choy; Andre Iffland; Siva Lavu; Oliver Medvedik; David A Sinclair; Jerrold M Olefsky; Michael R Jirousek; Peter J Elliott; Christoph H Westphal Journal: Nature Date: 2007-11-29 Impact factor: 49.962
Authors: Nathan L Price; Ana P Gomes; Alvin J Y Ling; Filipe V Duarte; Alejandro Martin-Montalvo; Brian J North; Beamon Agarwal; Lan Ye; Giorgio Ramadori; Joao S Teodoro; Basil P Hubbard; Ana T Varela; James G Davis; Behzad Varamini; Angela Hafner; Ruin Moaddel; Anabela P Rolo; Roberto Coppari; Carlos M Palmeira; Rafael de Cabo; Joseph A Baur; David A Sinclair Journal: Cell Metab Date: 2012-05-02 Impact factor: 27.287
Authors: Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk Journal: Am J Physiol Endocrinol Metab Date: 2019-03-19 Impact factor: 4.310
Authors: Ji H Kang; Ji E Park; Jason Dagoon; Stewart W C Masson; Troy L Merry; Shannon N Bremner; Jessica R Dent; Simon Schenk Journal: J Appl Physiol (1985) Date: 2021-04-22
Authors: Sheila R Costford; Bram Brouwers; Meghan E Hopf; Lauren M Sparks; Mauro Dispagna; Ana P Gomes; Heather H Cornnell; Chris Petucci; Peter Phelan; Hui Xie; Fanchao Yi; Glenn A Walter; Timothy F Osborne; David A Sinclair; Randall L Mynatt; Julio E Ayala; Stephen J Gardell; Steven R Smith Journal: Mol Metab Date: 2017-11-06 Impact factor: 7.422
Authors: Vitor F Martins; Shahriar Tahvilian; Ji H Kang; Kristoffer Svensson; Byron Hetrick; Wallace S Chick; Simon Schenk; Carrie E McCurdy Journal: Front Physiol Date: 2018-06-27 Impact factor: 4.566
Authors: Kristoffer Svensson; Samuel A LaBarge; Abha Sathe; Vitor F Martins; Shahriar Tahvilian; Jennifer M Cunliffe; Roman Sasik; Sushil K Mahata; Gretchen A Meyer; Andrew Philp; Larry L David; Samuel R Ward; Carrie E McCurdy; Joseph E Aslan; Simon Schenk Journal: J Cachexia Sarcopenia Muscle Date: 2020-01-03 Impact factor: 12.910